NYSE:PFE
Pfizer Inc (PFE)
30.03
-0.39 (1.28%)
as of Oct 23, 2026, 8:00:00 pm Market Closed.
585 watching
Financials 
Technical Analysis 0
BUY
His model price is $39.86, a 61% positive differential. In his top 10. The one consolation on this is that you get a 5% dividend while you wait. Hopes they will write off a lot of their Pharmacia acquisition. Until they do, he doesn't expect much movement.
Brian Acker, CAOwned
biotechnologypharmaceutical
BUY
Corrected partly because of the market and also its latest earnings report was somewhat disappointing even though the company advised that the full year and next year's earnings are expected to be as they previously stated. Almost 5% yield, which totally limits downside risk in the stock. On a market turn around, this will be a major participant.
Norman LevineOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick July 21/06 Up 1%.) Pays a 5% dividend. His model price is $41.35, a 71% positive differential.
Brian Acker, CAOwned
biotechnologypharmaceutical
DON'T BUY
Has been a very frustrating stock to have. Doesn't seem to be able to get out of its own way.
Brendan CaldwellOwned
biotechnologypharmaceutical
HOLD
Just reported numbers that were a little bit lighter than expectations. They also reaffirmed their view for next year that they expect to make back the shortfall later in the year. This knee-jerk reaction is an opportunity. 4.5% new.
Norman LevineOwned
biotechnologypharmaceutical
TOP PICK
The model price is $42, a 63% positive differential. All the drug companies are moving, except this one. Huge cash flows. 5% dividend yield.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
47% positive differential.
The most mispriced in the Dow Jones.
bonus of 5% dividend yield.
They are in around $26.63.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
(A Top Pick July 21/06. Up 14.5%.) 5% yield. His model price is $48.51, a 52% positive differential. The cheapest stock in the Dow Jones.
Brian Acker, CAOwned
biotechnologypharmaceutical
TOP PICK
Hasn't moved but has the most value of similar stocks. Massively mispriced.
Brian Acker, CAOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick May 9/06. Up 4.2%.) Yield gave him another 4%. Sold their consumers products division for $19 billion so have a huge amount of cash on the books. Can't see a lot of downside here.
Norman LevineOwned
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
